What Comes After Merck’s Keytruda? The Race for the Next Standard Cancer Treatment.

The pharmaceutical industry is actively seeking the next generation of cancer treatments to succeed Merck's Keytruda. The focus is on combining antibody-drug conjugates (ADCs) with augmented immunotherapies like bispecific antibodies, with several major pharmaceutical companies already involved in developing these innovative therapies.